Statement of Principles concerning malignant neoplasm of the eye No. 65 of 1999

Administered by Department of Veterans' Affairs

Legislation au F2008B00698 Not in force Legislative Instrument

Legislation content

Instrument No.65 of 1999

 

Determination

of

Statement of Principles

concerning

MALIGNANT NEOPLASM OF THE EYE

 

ICD-10-AM CODE: C69.0-C69.4, C69.8

 

Veterans’ Entitlements Act 1986

 

 

1. This Statement of Principles is determined by the Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act).

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about malignant neoplasm of the eye and death from malignant neoplasm of the eye.

 

(b) For the purposes of this Statement of Principles,

 

“malignant neoplasm of the eye” means a primary malignant neoplasm of the cells of the eye, attracting an ICD-10-AM code in the range C69.0 to C69.4, or C69.8, but excluding soft tissue sarcoma, non-Hodgkin’s lymphoma and Hodgkin’s disease of or affecting the eye. The eye means the conjunctiva, cornea, retina, uveal tract (choroid, ciliary body and iris) and eye ball, but excludes lacrimal gland and duct, orbit,  optic nerve and the skin and connective tissue of the eyelid.

 

Basis for determining the factors

3.                  On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that malignant neoplasm of the eye and death from malignant neoplasm of the eye can be related to relevant service rendered by veterans or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the eye or death from malignant neoplasm of the eye is connected with the circumstances of a person’s relevant service are:

 

(a) having a solar UV damage factor ratio of at least 1.2 before the clinical onset of malignant neoplasm of the eye; or

 

(b)            being infected with Human Immunodeficiency Virus (HIV) before the clinical onset of malignant neoplasm of the eye; or

 

(c) inability to obtain appropriate clinical management for malignant neoplasm of the eye.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(c) applies only to material contribution to, or aggravation of, malignant neoplasm of the eye where the person’s malignant neoplasm of the eye was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8. For the purposes of this Statement of Principles:

 

“being infected with Human Immunodeficiency Virus (HIV)” means serological evidence of infection with Human Immunodeficiency Virus;

 

“death from malignant neoplasm of the eye” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s malignant neoplasm of the eye;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), effective date of 1 July 1998, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86451 340 3;

 

“relevant service” means:

 

(a) eligible war service (other than operational service); or

(b) defence service (other than hazardous service);

 

“solar UV damage factor ratio” means the value obtained by applying the solar UV damage factor ratio formula which is:

 

total lifetime UV damage factor

non-service UV damage factor

 

where:

 

“total lifetime UV damage factor” means the numerical value calculated by the formula:

 

 T

 [MED cum (a,T)] -1  .  PAE (n,M,a) at age (T-t)  . t-

 t-0

 

for the person’s entire life, and where:

 

 has the value of five and is a numerical constant associated with the age dependence of the cumulative incidence;

 

 has the value of two and is a biological amplification factor;

 

“a” is an anatomical body site;

 

“M” is a specified month of the year;

 

“MED” means minimal erythemal dose, where one MED is equal to 200 Joules of radiation per square metre of skin;

 

“[MED cum (a,T)]” is the cumulative solar UV dose to the skin for any given anatomical body site for the person’s age at the time of the assessment;

“n” has the value specified in column 2 of Table 1 opposite the item in column 1 of that Table for each of the specified life activities set out in column 1:

 

Table 1—specified life activities

column 1

column 2

Service workday

1

Service weekend

2

Service recreation period one

3

Service recreation period two

4

Civilian workday

5

Civilian weekend

6

Civilian recreation period one

7

Civilian recreation period two

8

 

“PAE” means personal ambient exposure in MEDs, calculated for each and every month of a person’s life based on an estimate of a typical month during each of the five year periods between the ages of 0 and 20 years and each of the ten year periods thereafter;

 

“PAE (n,M,a)”means the number calculated by the formula:

 

n-8

 MAE (M,Ln) . ABFa . EFn . TRFn . ESFn . CPFn . ERFn . Wn

n-1

 

where:

 

“ABFa  is the anatomical body factor, and has the value specified in column 2 of Table 2 opposite the item in column 1 of that Table for each of the various body sites set out in column 1:

 

Table 2—body site

column 1

column 2

Face

0.15

 

“CPFn  is the clothing protection factor, and has the value assigned to a particular anatomical site proportionately according to the amount of protection provided by clothing and sun screen, ranging from a value of 1.00 for no protection to a value of 0.05 for full cover with heavy clothing for a given specified life activity in column 1 of Table 1;


“EFn is the exposure factor, and has the value specified in column 2 of Table 3 opposite the item in column 1 of that Table for different exposure situations set out in column 1:

 

Table 3—exposure situations

column 1

column 2

Indoor

0.10

Mainly indoor

0.20

Indoor and outdoor

0.35

Mainly outdoor

0.50

Outdoor

0.60

 

“ERFn” is the environment reflectance factor, and has the value specified in column 2 of Table 4 opposite the item in column 1 of that Table for the different environment types set out in column 1:

Table 4—environment types

column 1

column 2

Urban

0.95

Rural

1.00

Maritime

1.00

 

where:

 

“Urban” means a location that is either a city or a town;

 

“Rural” means a location that is bushland, pastoral, or agricultural setting;

 

“Maritime” means either on the sea, lake, major river, or directly adjacent to such a body of water;

 

“ESFn  is the environment shade factor, and has the value specified in column 2 of Table 5 opposite the item in column 1 of that Table for the different environment shade types set out in column 1:

 

Table 5—environment shade types

column 1

column 2

Dense shade

0.50

Moderate shade

0.70

Light shade

0.90

No shade

1.00

 

where:

  

“Dense shade” means a location that is predominantly under dense shade, such as jungle or dense forest;

 

“Moderate shade” means a location that is predominantly under moderate shade, such as open forest or high density housing;

 

“Light shade” means a location that is predominantly under light shade, such as lightly timbered country or low density housing;

 

“No shade”  means a location that is predominantly without shade, such as open fields, tundra, beach, or ocean;

 

“MAE(M,Ln)” is the average daily ambient exposure for month, M, in location, L, assuming a long term average cloud cover, being the value, obtained from the Table set out in Schedule 1, that is contained in the row that corresponds to the particular latitude (rounded to the nearest five degrees) and is contained in the column that corresponds to the month of the year that is the particular month under consideration, for each specified life activity;

 

“TRFn  is the terrain reflectance factor, and has the value specified in column 2 of Table 6 opposite the item in column 1 of that Table for the different terrain types set out in column 1:

 

Table 6—terrain types

column 1

column 2

Brown

1.02

Black 

1.04

Green

1.05

Open water

1.08

Sand

1.16

Snow

1.40

 

where:

 

“Black”  means a terrain predominantly of black material such as asphalt;

 

“Brown” means a terrain predominantly of bare soil, clay, or buildings;

 

“Green” means a terrain predominantly of green vegetation;

 

“Open Water” means an environment surrounded by water;

 

“Sand” means a terrain predominantly of light material such as white or yellow sand;

 

“Snow” means a terrain that is predominantly covered in snow;

 

“Wn is an estimate of the number of days in a month in which a specified life activity in column 1 of Table 1 is performed, and where, for the purposes of this definition, every month is taken to have 30.4375 days;

 

“t” is the age in months of the person for the particular specified activity;

 

“T” is the age in months of the person at the time of assessment;

 

and,

 

“non-service UV damage factor” means the numerical value calculated by the formula:

 

 T

 [MED cum (a,T)] -1  .  PAE (n,M,a) at age (T-t)  . t-

 t-0

 

for the person’s entire life, with the PAE for each month of the person’s period or periods of relevant service being the arithmetic mean of the PAE for each and every month of the person’s life, other than the period or periods of relevant service, where:

 

 has the value of five and is a numerical constant associated with the age dependence of the cumulative incidence;

 

 has the value of two and is a biological amplification factor;

 

“a” is an anatomical body site;

 

“M” is a specified month of the year;

 

“MED” means minimal erythemal dose, where one MED is equal to 200 Joules of radiation per square metre of skin;

 

“[MED cum (a,T)]” means the cumulative solar UV dose to the skin for any given anatomical body site for the person’s age at the time of the assessment;

 

“n” has the value specified in column 2 of Table 7 opposite the item in column 1 of that Table for each of the specified life activities set out in column 1:

 

Table 7—specified life activities

column 1

column 2

Service workday

1

Service weekend

2

Service recreation period one

3

Service recreation period two

4

Civilian workday

5

Civilian weekend

6

Civilian recreation period one

7

Civilian recreation period two

8

 

“PAE” means personal ambient exposure in MEDs, calculated for each and every month of a person’s life based on an estimate of a typical month during each of the five year periods between the ages of 0 and 20 years and each of the ten year periods thereafter;

 

“PAE (n,M,a)” is the numerical value calculated by the formula:

 

n-8

MAE (M,Ln) . ABFa . EFn . TRFn . ESFn . CPFn . ERFn . Wn

n-1

 

where:

 

“ABFa  is the anatomical body factor, and has the value specified in column 2 of Table 8 opposite the item in column 1 of that Table for each of the various body sites set out in column 1:

 

Table 8—body site

column 1

column 2

Face

0.15

 

“CPFn  is the clothing protection factor, and has the value assigned to a particular anatomical site proportionately according to the amount of protection provided by clothing and sun screen, ranging from a value of 1.00 for no protection to a value of 0.05 for full cover with heavy clothing for a given specified life activity in column 1 of Table 7;

 

“EFn is the exposure factor, and has the value specified in column 2 of Table 9 opposite the item in column 1 of that Table for different exposure situations set out in column 1:

 

Table 9—exposure situations

column 1

column 2

Indoor

0.10

Mainly indoor

0.20

Indoor and outdoor

0.35

Mainly outdoor

0.50

Outdoor

0.60

 

“ERFn” is the environment reflectance factor, and has the value specified in column 2 of Table 10 opposite the item in column 1 of that Table for the different environment types set out in column 1:

 

Table 10—environment types

column 1

column 2

Urban

0.95

Rural

1.00

Maritime

1.00

 

where;

 

“Urban” means a location that is either a city or a town;

 

“Rural” means a location that is bushland, pastoral, or agricultural setting;

 

“Maritime” means either on the sea, lake, major river, or directly adjacent to such a body of water;

 

“ESFn  is the environment shade factor, and has the value specified in column 2 of Table 11 opposite the item in column 1 of that Table for the different environment shade types set out in column 1:

 

Table 11—environment shade types

column 1

column 2

Dense shade

0.50

Moderate shade

0.70

Light shade

0.90

No shade

1.00

 

where:

  

“Dense shade” means a location that is predominantly under dense shade, such as jungle or dense forest;

 

“Moderate shade” means a location that is predominantly under moderate shade, such as open forest or high density housing;

 

“Light shade” means a location that is predominantly under light shade, such as lightly timbered country or low density housing;

 

“No shade”  means a location that is predominantly without shade, such as open fields, tundra, beach, or ocean;

 

“MAE(M,Ln)” is the average daily ambient exposure for month, M, in location, L, assuming a long term average cloud cover, being the value, obtained from the Table set out in Schedule 1, that is contained in the row that corresponds to the particular latitude (rounded to the nearest five degrees) and is contained in the column that corresponds to the month of the year that is the particular month under consideration, for each specified life activity;

 

“TRFn  is the terrain reflectance factor, and has the value specified in column 2 of Table 12 opposite the item in column 1 of that Table for the different terrain types set out in column 1:

 

Table 12—terrain types

column 1

column 2

Brown

1.02

Black 

1.04

Green

1.05

Open water

1.08

Sand

1.16

Snow

1.40

 

where:

 

“Black”  means a terrain predominantly of black material such as asphalt;

 

“Brown” means a terrain predominantly of bare soil, clay, or buildings;

 

“Green” means a terrain predominantly of green vegetation;

 

“Open Water” means an environment surrounded by water;

 

“Sand” means a terrain predominantly of light material such as white or yellow sand;

 

“Snow” means a terrain that is predominantly covered in snow;

 

“Wn is an estimate of the number of days in a month in which a specified life activity in column 1 of Table 7 is performed, and where, for the purposes of this definition, every month is taken to have 30.4375 days;

 

“t” is the age in months of the person for the particular specified activity;

 

“T” is the age in months of the person at the time of assessment;

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

a) pneumonia;

b) respiratory failure;

c) cardiac arrest;

d) circulatory failure; or

e)                  cessation of brain function.

 

Application

9. This Instrument applies to all matters to which section 120B of the Act applies.

 

 


Schedule 1

 

Average daily MED calculated for the given month and latitude

Data assumes long-term average cloud cover

 

Latitude

January

February

March

April

May

June

July

August

September

October

November

December

85°N

0.00

0.10

0.10

0.10

0.10

1.00

1.00

0.10

0.10

0.10

0.10

0.00

80°N

0.00

0.10

0.20

1.00

2.00

3.00

3.00

2.00

0.50

0.10

0.10

0.00

75°N

0.00

0.10

0.50

2.00

3.00

5.00

5.00

3.00

1.00

0.20

0.10

0.00

70°N

0.00

0.21

0.90

2.95

5.81

7.83

8.01

5.17

1.97

0.44

0.07

0.00

65°N

0.21

0.62

1.66

4.13

7.06

9.42

9.49

6.72

3.11

1.08

0.35

0.18

60°N

0.41

1.03

2.42

5.30

8.32

11.11

11.05

8.38

4.28

1.72

0.60

0.35

55°N

0.62

1.44

3.18

6.48

9.94

12.71

12.71

10.14

5.76

2.61

0.90

0.53

50°N

0.82

1.85

3.95

7.66

11.66

14.37

14.46

12.01

7.37

3.64

1.22

0.71

45°N

1.97

3.46

5.97

9.67

13.35

16.25

15.98

14.68

9.69

5.62

2.67

1.79

40°N

3.12

5.06

7.99

11.68

15.03

18.24

17.51

17.60

12.15

7.66

4.28

2.87

35°N

4.51

7.00

10.45

14.18

17.56

20.58

19.72

19.54

14.74

9.94

6.00

4.24

30°N

6.03

9.10

13.07

16.81

20.25

23.07

22.03

21.48

17.48

12.35

7.86

5.76

25°N

8.86

12.36

16.41

19.68

22.04

22.89

21.58

21.17

18.59

14.74

10.39

8.38

20°N

11.77

15.73

19.91

22.69

23.88

22.68

21.10

20.72

19.57

17.14

12.91

11.01

15°N

14.02

17.69

20.55

21.94

21.88

19.98

19.14

19.27

18.72

17.51

14.81

13.06

10°N

16.07

19.41

20.93

21.04

19.83

17.38

17.26

17.81

17.65

17.47

16.35

14.87

 5°N

17.89

19.98

20.28

19.82

18.20

16.31

16.42

17.37

18.68

18.38

17.09

16.49

Equator

19.58

20.35

19.50

18.60

16.65

15.23

15.58

16.93

19.73

19.28

17.73

18.03

5°S

19.41

20.20

19.64

19.81

17.95

16.49

17.39

19.53

22.03

21.63

20.12

19.16

10°S

19.07

20.03

19.76

20.67

18.58

16.95

18.39

21.54

24.12

24.05

22.67

20.16

15°S

23.08

23.28

22.11

19.86

15.96

14.10

15.46

18.73

22.52

24.21

24.43

23.55

20°S

25.26

24.18

21.92

17.36

12.73

10.81

11.94

15.38

19.95

24.03

26.40

25.74

25°S

25.63

23.95

20.30

14.64

9.97

7.91

8.76

11.77

16.29

20.70

24.36

25.80

30°S

25.96

23.59

18.60

11.97

7.32

5.25

5.85

8.45

12.87

17.56

22.39

25.85

35°S

22.99

20.31

15.45

9.42

5.53

3.99

4.38

6.46

10.23

14.48

19.13

22.54

40°S

20.18

17.23

12.51

7.06

3.90

2.80

3.05

4.66

7.82

11.66

16.13

19.45

45°S

17.42

14.15

9.57

5.00

2.62

1.79

2.00

3.29

5.90

9.57

13.77

16.92

50°S

15.74

12.14

7.43

3.18

1.30

0.75

0.90

1.87

4.15

7.68

12.20

15.53

55°S

14.16

10.46

6.08

2.49

1.00

0.57

0.67

1.46

3.40

6.68

10.87

13.99

60°S

12.57

8.78

4.74

1.80

0.69

0.38

0.45

1.04

2.64

5.68

9.53

12.45

65°S

10.98

7.09

3.39

1.11

0.38

0.19

0.22

0.62

1.89

4.68

8.20

10.92

70°S

9.40

5.41

2.05

0.42

0.08

0.00

0.00

0.21

1.14

3.68

6.86

9.38

75°S

6.00

3.00

1.00

0.20

0.10

0.00

0.00

0.10

1.00

2.50

4.00

5.00

80°S

3.00

1.50

0.50

0.10

0.10

0.00

0.00

0.00

0.50

1.50

1.50

2.00

85°S

1.00

0.50

0.10

0.10

0.10

0.00

0.00

0.00

0.10

1.00

1.00

2.00

 

 

Dated this Twenty-eighth day of October 1999

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of    )

 

KEN DONALD

CHAIRMAN

 

Overview

The Veterans' Entitlements Act 1986, enacted in 1986, addresses the need to provide entitlements and benefits to veterans, their families, and dependents for injuries, diseases, and deaths related to service in the Australian Defence Force. This Act was established by the Parliament of Australia to provide a comprehensive framework for the recognition and support of veterans and their loved ones. The Statement of Principles concerning Malignant Neoplasm of the Eye, determined under subsection 196B(3) of the Veterans' Entitlements Act 1986 by the Repatriation Medical Authority, provides the policy objective of recognising the link between malignant neoplasm of the eye and service in the Australian Defence Force. This determination ensures that veterans who have served and subsequently developed malignant neoplasm of the eye, or who died from the condition, can access the necessary support and benefits.

Scope and Application

This legislative instrument, F2008B00698, is a Statement of Principles concerning malignant neoplasm of the eye, established under the Veterans’ Entitlements Act 1986. It applies to veterans and members of the Australian Defence Force who have developed a malignant neoplasm of the eye or who have died from such a neoplasm. The scope of the Act encompasses specific types of malignant neoplasms of the eye, identified by ICD-10-AM codes C69.0 to C69.4 and C69.8, while excluding conditions such as soft tissue sarcoma, non-Hodgkin’s lymphoma, and Hodgkin’s disease affecting the eye. The legislation stipulates that for a malignant neoplasm of the eye to be considered related to service, certain factors must be present, such as a solar UV damage factor ratio of at least 1.2, infection with Human Immunodeficiency Virus (HIV) before the onset of the neoplasm, or inability to obtain appropriate clinical management. The instrument also delineates the geographic application of the Act by specifying the conditions under which the malignant neoplasm of the eye can be considered to be connected to relevant service, such as eligible war service or defence service. This Statement of Principles aims to provide clarity and guidance for veterans and their representatives regarding the eligibility criteria for veterans’ entitlements related to malignant neoplasm of the eye.

Key Provisions

The Statement of Principles, as outlined in the legislation, pertains to malignant neoplasm of the eye and death caused by such neoplasms (section 2). The Repatriation Medical Authority has determined that it is more probable than not that these conditions can be related to the service rendered by veterans or members of the forces (section 3). To establish a connection between the malignant neoplasm of the eye or death from such neoplasms and the service rendered by an individual, at least one of the specified factors must be related to that service (section 4). These factors include a solar UV damage factor ratio of at least 1.2 before the onset of the neoplasm, infection with Human Immunodeficiency Virus (HIV) before the onset, or the inability to obtain appropriate clinical management for the neoplasm (section 5). Certain factors may only apply to cases where the malignant neoplasm of the eye was suffered or contracted before or during service, but not as a result of the service (section 6). The Statement of Principles applies to all matters to which section 120B of the Veterans' Entitlements Act 1986 relates (section 9). In cases where a relevant factor includes an injury or disease for which there is already a Statement of Principles, the factors in that existing Statement of Principles will apply in accordance with its terms (section 7). Definitions provided in the Statement of Principles include "being infected with Human Immunodeficiency Virus (HIV)", "death from malignant neoplasm of the eye", "ICD-10-AM code", "relevant service", "solar UV damage factor ratio", and "terminal event" (section 8). The legislation imposes certain obligations on the parties it governs, including the requirement for at least one of the specified factors to be related to the relevant service rendered by an individual for a connection to be established between the malignant neoplasm of the eye or death from such neoplasms and the service. Additionally, the Statement of Principles applies to all matters to which section 120B of the Veterans' Entitlements Act 1986 relates. There are no explicit offences, penalties, or civil/criminal consequences mentioned in the text for breach of the provisions in the Statement of Principles. However, it is important to note that the determination of entitlement to benefits under the Veterans' Entitlements Act 1986 may be subject to other provisions and regulations within that Act.

Legal classification tags

Area of Law
Veterans’ Entitlements
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Enforcement Powers

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.